Vascular Grafts Market

Vascular Grafts Market (Product: Endovascular Stent Graft, Peripheral Vascular Graft, Hemodialysis Access Graft, Bypass Graft, and Others; Source: Synthetic, Biological, and Biosynthetic) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Vascular Grafts Market Outlook 2031

  • The global market size was valued at US$ 2.0 Bn in 2021
  • It is projected to grow at a CAGR of 5.6% from 2022 to 2031 and reach more than US$ 3.7 Bn by the end of 2031

Analysts’ Viewpoint

Usage of vascular grafts is rising at a rapid pace owing to an increase in incidence of health conditions such as chronic kidney and cardiovascular diseases.

Rise in the number of lifestyle-related disorders, surge in the geriatric population, increase in health care expenditure, and improvement in healthcare infrastructure are driving the demand for vascular graft surgeries or procedures.

Government and regulatory bodies of various countries are adopting cost-containment measures to reduce the health care burden, especially in developed economies. This shift from volume- to value-based system is driven by various measures taken by governments, health care providers, insurance payers, and life sciences companies.

Leading vascular graft companies, including Terumo Corporation and Vascular Graft Solutions, play a crucial role in the development of these grafts.

Vascular Grafts Market

Vascular Grafts Market Introduction

Vascular surgery involves rerouting blocked or narrowed artery in order to restore the blood flow to a specific organ (heart, brain, leg, etc.). Surgeons use a synthetic or natural graft to connect to a healthy artery to the narrowed artery beyond the blocked point in order to create another path for the blood flow. Different types of vascular bypass graft surgeries can be performed depending on the location of the blockage.

Vascular bypass graft surgery is an inpatient procedure performed by a cardiothoracic surgeon, neurosurgeon, or vascular surgeon in hospital setting. Bypass surgeries are mostly scheduled in advance. For each bypass surgery, a graft must be chosen to create a new route around the blocked section of the artery.

The graft could be taken from a vein or artery, or it can be synthetic. Objective vascular bypass surgery is performed to bypass the blocked or narrow artery and restore the blood flow. The most common bypass surgeries are coronary artery bypass grafting/surgery, cerebral artery bypass surgery, renal artery bypass surgery, aortoiliac or aortofemoral bypass surgery, and peripheral bypass surgery.

Request a sample to get extensive insights into the Vascular Grafts Market

Increase in Incidence of Various Vascular Diseases to Boost Market Growth

Chronic kidney disease (CKD), also known as chronic kidney failure, is one of the major risk factors for diabetes, hypertension, cardiovascular diseases, and others diseases. It involves a gradual loss of the kidney function. Advanced chronic kidney disease can lead to dangerous levels of fluids, electrolytes, and waste build up in the body.

According to the National Institute of Diabetes & Digestive & Kidney Diseases, more than 37 million adults in the U.S. have CKD. According to the Centers for Disease Control and Prevention, diabetes and high blood pressure are the leading causes of kidney failure in the country, accounting for three out of four new cases.

Consumption of alcohol & tobacco and hereditary factors increase the number of cardiovascular disorders. According to the WHO, cardiovascular diseases (CVDs) accounted for an estimated 17.9 million deaths in 2019, representing 32% of all global deaths. Of these, around 85% were due to heart attack and stroke. Moreover, rise in the number of cancer cases increases the demand for central venous catheters and implantable ports & grafts for the administration of chemotherapy medications and blood transfusion.

Increase in Number of Lifestyle-related Disorders to Boost Demand for Vascular Grafts

Incidence of lifestyle-related disorders such as diabetes, blood pressure, and obesity has increased due to unhealthy lifestyle & diet and lack of exercise. According to the International Diabetes Federation (IDF), around 527 million adults across the world were living with diabetes in 2021, and the number is expected to rise to 643 million by 2030 and 783 million by 2045. Hypertension, or elevated blood pressure, is another disorder caused by unhealthy diet or excessive salt consumption, physical inactivity, or overweight/obesity.

According to the WHO, globally, an estimated 1.28 billion adults aged 30 years to 79 years have hypertension, especially people living in low and middle income countries. Hence, increase in the incidence of lifestyle-related disorders among the global population propels the need for hospitalization, which in turn augments the global demand.

Request a custom report on Vascular Grafts Market

Non-invasive Surgical Procedure Fueling Endovascular Stent Grafts Segment

In terms of product, the global vascular grafts market has been classified into endovascular stent graft, peripheral vascular graft, hemodialysis access graft, bypass graft, and others. The endovascular stent grafts segment dominated the global industry in terms of share in 2021. This stent graft usually supports the weak areas of the aorta. It is a non-invasive surgical procedure used to treat abdominal aortic aneurysm.

Ability to Re-adjust Wall Configuration Bolstering Synthetic Segment

Based on source, the global vascular grafts market has been segregated into biological, synthetic, and biosynthetic. The synthetic segment accounted for major share in 2021. Synthetic vascular grafts are non-toxic, non-allergenic grafts made of materials such as Teflon, glass, or lead. These have the ability to re-adjust the wall configuration to form a good mechanical fit, while making an opening in blood vessels or diverging them.

High Patency Rate Fueling Demand for Large Size Vascular Grafts

In terms of size of vascular graft, the global vascular grafts business has been bifurcated into large size vascular grafts and small size vascular grafts. Large size vascular grafts accounted for major share of the market demand in 2021. Advantages such as wide availability, high patency rate, and constant flow of blood are driving the large size vascular grafts segment.

Increase in Incidence of Cardiovascular Diseases to Propel Coronary Artery Bypass Segment

Based on application, the global vascular grafts market has been divided into coronary artery bypass, aneurysm, vascular occlusion, renal failure, critical limb ischemia, and others.

The coronary artery bypass segment held a dominant share in 2021 due to increase in the incidence of cardiovascular diseases and rise in demand for treatment procedures. According to the WHO, about 17.9 million people succumb to cardiovascular diseases every year, which is 32% of total global deaths.

Highly Favorable Settings for Procedures Requiring Vascular Access Propelling Hospitals Segment

In terms of end-user, the market segmentation comprises hospitals, ambulatory surgical centers, cardiac catheterization laboratories, specialty clinics, and others. The hospitals segment held the largest market share in 2021. Hospitals are the most preferred choice and highly favorable settings for procedures requiring vascular access, ranging from cardiovascular to dialysis. Therefore, the segment is expected to grow at a rapid pace during the forecast period.

Regional Analysis

North America accounted for major share of the global vascular grafts market in 2021. The U.S. dominated the region due to large patient pool, high prevalence of heart diseases, advancements in clinical trials for various vascular disorders & diseases, and surge in demand among vascular surgeons for the development of new products. According to the Centers for Disease Control and Prevention, about 697,000 people in the U.S. succumbed to heart disease in 2020 i.e., 1 in every 5 deaths; one person dies every 34 seconds in the country from cardiovascular disease.

Asia Pacific is expected to be the fastest growing region during the forecast period. According to the America College of Cardiology, in 2019, CVD accounted for 9.6 million deaths among men and 8.9 million deaths among women. Furthermore, over 6 million of these deaths occurred in people aged between 30 and 70. The highest number of CVD deaths occurred in China, followed by India, Russia and Indonesia. Moreover, demand for vascular graft modification among surgeons is increasing owing to rise in the number of awareness programs by vascular associations across Asia Pacific. Surge in the incidence of coronary artery disease is likely to drive market expansion in the region.

Analysis of Key Players

The global industry is consolidated, with the presence of a small number of large companies. Majority of these players are investing significantly in research & development to develop advanced vascular grafts.

Expansion of product portfolio and mergers & acquisitions are prominent strategies adopted by key players. Prominent players in the industry are B. Braun SE, Becton, Dickinson and Company, Cook Medical, Inc., CryoLife, Inc., Getinge AB, Heart Medical, Junken Medical Co., Ltd., LeMaitre Vascular, Inc., Medtronic, Vascular Graft Solutions, and W. L. Gore & Associates, Inc.

Key Developments in Global Vascular Grafts Market

  • In September 2021, Terumo Aortic announced the launch of its global surgical graft study, known as ‘PANTHER’
  • In March 2021, Vascular Graft Solutions, one of the leading manufacturers of medical devices, announced receipt of marketing clearance from the Food and Drug Administration (FDA) for ‘VIOLA’, a new device for clampless proximal anastomosis in coronary artery bypass grafting (CABG)
  • In November 2019, Terumo Corporation acquired Aortica Corporation to expand its product line

Leading players in the industry have been profiled in the report based on parameters such as company overview, financial standing, strategies, portfolio, segments, and recent developments.

Global Vascular Grafts Market Snapshot

Attribute

Detail

Size in 2021

US$ 2.0 Bn

Forecast Value in 2031

US$ 3.7 Bn

Growth Rate

(CAGR)

 5.6%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product
    • Endovascular Stent Graft
    • Peripheral Vascular Graft
    • Hemodialysis Access Graft
    • Bypass Graft
    • Others
  • Source
    • Synthetic
      • Polytetrafluethylene (PTFE)
      • Polyurethane (PU)
      • Dacron
      • Others
    • Biological
      • Bovine Vein
      • Saphenous Vein
      • Others
    • Biosynthetic
      • Ovine Collagen with Polyester
      • Others
  • Size of Vascular Graft
    • Large Size Vascular Graft
    • Small Size Vascular Graft
  • Application
    • Coronary Artery Bypass
    • Aneurysm
    • Vascular Occlusion
    • Critical Limb Ischemia
    • Renal Failure
    • Others
  • End-user
    • Hospitals
    • Ambulatory Surgery Centers
    • Cardiac Catheterization Laboratories
    • Specialty Clinics
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia & CIS
  • Japan
  • China
  • India
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • B. Braun SE
  • Becton, Dickson and Company (BD)
  • Cook Medical, Inc.
  • CryoLife, Inc.
  • Getinge AB
  • Heart Medical
  • JUNKEN MEDICAL Co., Ltd.
  • LeMaitre Vascular, Inc.
  • Medtronic
  • Terumo Corporation
  • Vascular Graft Solutions
  • W. L. Gore & Associates, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global vascular grafts market in 2021?

The global market was valued at US$ 2.0 Bn in 2021

How big will the vascular grafts industry be in 2031?

It is projected to reach a value of more than US$ 3.7 Bn by 2031

What was the CAGR from 2017 to 2021?

The CAGR contracted at 1.7% from 2017 to 2021

What will be the CAGR of vascular grafts business during the forecast period?

The market is anticipated to grow at a CAGR of 5.6% from 2022 to 2031

What are the prominent trends that affect market growth of vascular grafts?

Increase in the incidence of target diseases and rise in the number of lifestyle-related disorders.

Which region is likely to account for major share during the forecast period?

North America is expected to account for the largest share.

Who are the prominent players in the global vascular grafts industry?

Braun SE, BD, Cook Medical, Inc., CryoLife, Inc., Getinge AB, Heart Medical, Junken Medical Co., Ltd., LeMaitre Vascular, Inc., Medtronic, Vascular Graft Solutions, and W. L. Gore & Associates, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Vascular Grafts Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Vascular Grafts Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Global Prevalence of Chronic Kidney Diseases

        5.3. Global Prevalence of Cardiovascular Diseases

        5.4. Covid-19 Pandemic Impact on the Industry

    6. Global Vascular Grafts Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Endovascular Stent Graft

            6.3.2. Peripheral Vascular Graft

            6.3.3. Hemodialysis Access Graft

            6.3.4. Bypass Graft

            6.3.5. Others

        6.4. Market Attractiveness Analysis, by Product

    7. Global Vascular Grafts Market Analysis and Forecast, by Size of Vascular Graft

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031

            7.3.1. Large Size Vascular Graft

            7.3.2. Small Size Vascular Graft

        7.4. Market Attractiveness Analysis, by Size of Vascular Graft

    8. Global Vascular Grafts Market Analysis and Forecast, by Source

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Source, 2017–2031

            8.3.1. Synthetic

                8.3.1.1. Polytetrafluethylene (PTFE)

                8.3.1.2. Polyurethane (PU)

                8.3.1.3. Dacron

                8.3.1.4. Others

            8.3.2. Biological

                8.3.2.1. Bovine Vein

                8.3.2.2. Saphenous Vein

                8.3.2.3. Others

            8.3.3. Biosynthetic

                8.3.3.1. Ovine Collagen with Polyester

                8.3.3.2. Others

        8.4. Market Attractiveness Analysis, by Source

    9. Global Vascular Grafts Market Analysis and Forecast, by Application

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by Application, 2017–2031

            9.3.1. Coronary Artery Bypass

            9.3.2. Aneurysm

            9.3.3. Vascular Occlusion

            9.3.4. Critical Limb Ischemia

            9.3.5. Renal Failure

            9.3.6. Others

        9.4. Market Attractiveness Analysis, by Application

    10. Global Vascular Grafts Market Analysis and Forecast, by End-user

        10.1. Introduction & Definition

        10.2. Key Findings / Developments

        10.3. Market Value Forecast, by End-user, 2017–2031

            10.3.1. Hospitals

            10.3.2. Ambulatory Surgery Centers

            10.3.3. Cardiac Catheterization Laboratories

            10.3.4. Specialty Clinics

            10.3.5. Others

        10.4. Market Attractiveness Analysis, by End-user

    11. Global Vascular Grafts Market Analysis and Forecast, by Region

        11.1. Key Findings

        11.2. Market Value Forecast, by Region

            11.2.1. North America

            11.2.2. Europe

            11.2.3. Asia Pacific

            11.2.4. Latin America

            11.2.5. Middle East & Africa

        11.3. Market Attractiveness Analysis, by Region

    12. North America Vascular Grafts Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Endovascular Stent Graft

            12.2.2. Peripheral Vascular Graft

            12.2.3. Hemodialysis Access Graft

            12.2.4. Bypass Graft

            12.2.5. Others

        12.3. Market Value  Forecast, by Size of Vascular Graft, 2017–2031

            12.3.1. Large Size Vascular Graft

            12.3.2. Small Size Vascular Graft

        12.4. Market Value Forecast, by Source, 2017–2031

            12.4.1. Synthetic

                12.4.1.1. Polytetrafluethylene (PTFE)

                12.4.1.2. Polyurethane (PU)

                12.4.1.3. Dacron

                12.4.1.4. Others

            12.4.2. Biological

                12.4.2.1. Bovine Vein

                12.4.2.2. Saphenous Vein

                12.4.2.3. Others

            12.4.3. Biosynthetic

                12.4.3.1. Ovine Collagen with Polyester

                12.4.3.2. Others

        12.5. Market Value Forecast, by Application , 2017–2031

            12.5.1. Coronary Artery Bypass

            12.5.2. Aneurysm

            12.5.3. Vascular Occlusion

            12.5.4. Critical Limb Ischemia

            12.5.5. Renal Failure

            12.5.6. Others

        12.6. Market Value Forecast, by End-user, 2017–2031

            12.6.1. Hospitals

            12.6.2. Ambulatory Surgery Centers

            12.6.3. Cardiac Catheterization Laboratories

            12.6.4. Specialty Clinics

            12.6.5. Others

        12.7. Market Value Forecast, by Country, 2017–2031

            12.7.1. U.S.

            12.7.2. Canada

        12.8. Market Attractiveness Analysis

            12.8.1. By Product

            12.8.2. By Size of Vascular Graft

            12.8.3. By Source

            12.8.4. By Application

            12.8.5. By End-user

            12.8.6. By Country

    13. Europe Vascular Grafts Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. Endovascular Stent Graft

            13.2.2. Peripheral Vascular Graft

            13.2.3. Hemodialysis Access Graft

            13.2.4. Bypass Graft

            13.2.5. Others

        13.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031

            13.3.1. Large Size Vascular Graft

            13.3.2. Small Size Vascular Graft

        13.4. Market Value Forecast, by Source, 2017–2031

            13.4.1. Synthetic

                13.4.1.1. Polytetrafluethylene (PTFE)

                13.4.1.2. Polyurethane (PU)

                13.4.1.3. Dacron

                13.4.1.4. Others

            13.4.2. Biological

                13.4.2.1. Bovine Vein

                13.4.2.2. Saphenous Vein

                13.4.2.3. Others

            13.4.3. Biosynthetic

                13.4.3.1. Ovine Collagen with Polyester

                13.4.3.2. Others

        13.5. Market Value Forecast, by Application, 2017–2031

            13.5.1. Coronary Artery Bypass

            13.5.2. Aneurysm

            13.5.3. Vascular Occlusion

            13.5.4. Critical Limb Ischemia

            13.5.5. Renal Failure

            13.5.6. Others

        13.6. Market Value Forecast, by End-user, 2017–2031

            13.6.1. Hospitals

            13.6.2. Ambulatory Surgery Centers

            13.6.3. Cardiac Catheterization Laboratories

            13.6.4. Specialty Clinics

            13.6.5. Others

        13.7. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.7.1. Germany

            13.7.2. U.K.

            13.7.3. France

            13.7.4. Italy

            13.7.5. Spain

            13.7.6. Rest of Europe

        13.8. Market Attractiveness Analysis

            13.8.1. By Product

            13.8.2. By Size of Vascular Graft

            13.8.3. By Source

            13.8.4. By Application

            13.8.5. By End-user

            13.8.6. By Country/Sub-region

    14. Asia Pacific Vascular Grafts Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product, 2017–2031

            14.2.1. Endovascular Stent Graft

            14.2.2. Peripheral Vascular Graft

            14.2.3. Hemodialysis Access Graft

            14.2.4. Bypass Graft

            14.2.5. Others

        14.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031

            14.3.1. Large Size Vascular Graft

            14.3.2. Small Size Vascular Graft

        14.4. Market Value Forecast, by Source, 2017–2031

            14.4.1. Synthetic

                14.4.1.1. Polytetrafluethylene (PTFE)

                14.4.1.2. Polyurethane (PU)

                14.4.1.3. Dacron

                14.4.1.4. Others

            14.4.2. Biological

                14.4.2.1. Bovine Vein

                14.4.2.2. Saphenous Vein

                14.4.2.3. Others

            14.4.3. Biosynthetic

                14.4.3.1. Ovine Collagen with Polyester

                14.4.3.2. Others

        14.5. Market Value  Forecast, by Application, 2017–2031

            14.5.1. Coronary Artery Bypass

            14.5.2. Aneurysm

            14.5.3. Vascular Occlusion

            14.5.4. Critical Limb Ischemia

            14.5.5. Renal Failure

            14.5.6. Others

        14.6. Market Value  Forecast, by End-user, 2017–2031

            14.6.1. Hospitals

            14.6.2. Ambulatory Surgery Centers

            14.6.3. Cardiac Catheterization Laboratories

            14.6.4. Specialty Clinics

            14.6.5. Others

        14.7. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.7.1. China

            14.7.2. Japan

            14.7.3. India

            14.7.4. Australia & New Zealand

            14.7.5. Rest of Asia Pacific

        14.8. Market Attractiveness Analysis

            14.8.1. By Product

            14.8.2. By Size of Vascular Graft

            14.8.3. By Source

            14.8.4. By Application

            14.8.5. By End-user

            14.8.6. By Country/Sub-region

    15. Latin America Vascular Grafts Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Product, 2017–2031

            15.2.1. Endovascular Stent Graft

            15.2.2. Peripheral Vascular Graft

            15.2.3. Hemodialysis Access Graft

            15.2.4. Bypass Graft

            15.2.5. Others

        15.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031

            15.3.1. Large Size Vascular Graft

            15.3.2. Small Size Vascular Graft

        15.4. Market Value  Forecast, by Source, 2017–2031

            15.4.1. Synthetic

                15.4.1.1. Polytetrafluethylene (PTFE)

                15.4.1.2. Polyurethane (PU)

                15.4.1.3. Dacron

                15.4.1.4. Others

            15.4.2. Biological

                15.4.2.1. Bovine Vein

                15.4.2.2. Saphenous Vein

                15.4.2.3. Others

            15.4.3. Biosynthetic

                15.4.3.1. Ovine Collagen with Polyester

                15.4.3.2. Others

        15.5. Market Value  Forecast, by Application , 2017–2031

            15.5.1. Coronary Artery Bypass

            15.5.2. Aneurysm

            15.5.3. Vascular Occlusion

            15.5.4. Critical Limb Ischemia

            15.5.5. Renal Failure

            15.5.6. Others

        15.6. Market Value Forecast, by End-user, 2017–2031

            15.6.1. Hospitals

            15.6.2. Ambulatory Surgery Centers

            15.6.3. Cardiac Catheterization Laboratories

            15.6.4. Specialty Clinics

            15.6.5. Others

        15.7. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.7.1. Brazil

            15.7.2. Mexico

            15.7.3. Rest of Latin America

        15.8. Market Attractiveness Analysis

            15.8.1. By Product

            15.8.2. By Size of Vascular Graft

            15.8.3. By Source

            15.8.4. By Application

            15.8.5. By End-user

            15.8.6. By Country/Sub-region

    16. Middle East & Africa Vascular Grafts Market Analysis and Forecast

        16.1. Introduction

            16.1.1. Key Findings

        16.2. Market Value Forecast, by Product, 2017–2031

            16.2.1. Endovascular Stent Graft

            16.2.2. Peripheral Vascular Graft

            16.2.3. Hemodialysis Access Graft

            16.2.4. Bypass Graft

            16.2.5. Others

        16.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031

            16.3.1. Large Size Vascular Graft

            16.3.2. Small Size Vascular Graft

        16.4. Market Value Forecast, by Source, 2017–2031

            16.4.1. Synthetic

                16.4.1.1. Polytetrafluethylene (PTFE)

                16.4.1.2. Polyurethane (PU)

                16.4.1.3. Dacron

                16.4.1.4. Others

            16.4.2. Biological

                16.4.2.1. Bovine Vein

                16.4.2.2. Saphenous Vein

                16.4.2.3. Others

            16.4.3. Biosynthetic

                16.4.3.1. Ovine Collagen with Polyester

                16.4.3.2. Others

        16.5. Market Value  Forecast, by Application, 2017–2031

            16.5.1. Coronary Artery Bypass

            16.5.2. Aneurysm

            16.5.3. Vascular Occlusion

            16.5.4. Critical Limb Ischemia

            16.5.5. Renal Failure

            16.5.6. Others

        16.6. Market Value Forecast, by End-user, 2017–2031

            16.6.1. Hospitals

            16.6.2. Ambulatory Surgery Centers

            16.6.3. Cardiac Catheterization Laboratories

            16.6.4. Specialty Clinics

            16.6.5. Others

        16.7. Market Value Forecast, by Country/Sub-region, 2017–2031

            16.7.1. GCC Countries

            16.7.2. South Africa

            16.7.3. Rest of Middle East & Africa

        16.8. Market Attractiveness Analysis

            16.8.1. By Product

            16.8.2. By Size of Vascular Graft

            16.8.3. By Source

            16.8.4. By Application

            16.8.5. By End-user

            16.8.6. By Country/Sub-region

    17. Competition Landscape

        17.1. Market Player - Competition Matrix (by tier and size of companies)

        17.2. Market Share Analysis, by Company, 2021

        17.3. Company Profiles

            17.3.1. B. Braun SE

                17.3.1.1. Company Overview

                17.3.1.2. Product Portfolio

                17.3.1.3. SWOT Analysis

                17.3.1.4. Strategic Overview

            17.3.2. BD

                17.3.2.1. Company Overview

                17.3.2.2. Product Portfolio

                17.3.2.3. SWOT Analysis

                17.3.2.4. Strategic Overview

            17.3.3. Cook Medical, Inc.

                17.3.3.1. Company Overview

                17.3.3.2. Product Portfolio

                17.3.3.3. SWOT Analysis

                17.3.3.4. Strategic Overview

            17.3.4. CryoLife, Inc.

                17.3.4.1. Company Overview

                17.3.4.2. Product Portfolio

                17.3.4.3. SWOT Analysis

                17.3.4.4. Strategic Overview

            17.3.5. Getinge AB

                17.3.5.1. Company Overview

                17.3.5.2. Product Portfolio

                17.3.5.3. SWOT Analysis

                17.3.5.4. Strategic Overview

            17.3.6. Heart Medical

                17.3.6.1. Company Overview

                17.3.6.2. Product Portfolio

                17.3.6.3. SWOT Analysis

                17.3.6.4. Strategic Overview

            17.3.7. JUNKEN MEDICAL Co., Ltd.

                17.3.7.1. Company Overview

                17.3.7.2. Product Portfolio

                17.3.7.3. SWOT Analysis

                17.3.7.4. Strategic Overview

            17.3.8. LeMaitre Vascular, Inc.

                17.3.8.1. Company Overview

                17.3.8.2. Product Portfolio

                17.3.8.3. SWOT Analysis

                17.3.8.4. Strategic Overview

            17.3.9. Medtronic

                17.3.9.1. Company Overview

                17.3.9.2. Product Portfolio

                17.3.9.3. SWOT Analysis

                17.3.9.4. Strategic Overview

            17.3.10. Terumo Corporation

                17.3.10.1. Company Overview

                17.3.10.2. Product Portfolio

                17.3.10.3. SWOT Analysis

                17.3.10.4. Strategic Overview

            17.3.11. Vascular Graft Solutions

                17.3.11.1. Company Overview

                17.3.11.2. Product Portfolio

                17.3.11.3. SWOT Analysis

                17.3.11.4. Strategic Overview

            17.3.12. W. L. Gore & Associates, Inc.

                17.3.12.1. Company Overview

                17.3.12.2. Product Portfolio

                17.3.12.3. SWOT Analysis

                17.3.12.4. Strategic Overview

    List of Tables

    Table 01: Global Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 02: Global Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031

    Table 03: Global Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic Source, 2017‒2031

    Table 04: Global Vascular Graft Market Value (US$ Mn) Forecast, by Biological Source, 2017‒2031

    Table 05: Global Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic Source, 2017‒2031

    Table 06: Global Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017‒2031

    Table 07: Global Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 08: Global Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 09: Global Vascular Graft Market Value (US$ Mn) Forecast, by Region, 2017‒2031

    Table 10: North America Vascular Graft Market Value (US$ Mn) Forecast, by Country, 2017‒2031

    Table 11: North America Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 12: North America Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031

    Table 13: North America Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017‒2031

    Table 14: North America Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017‒2031

    Table 15: North America Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017‒2031

    Table 16: North America Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017‒2031

    Table 17: North America Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 18: North America Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 19: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031

    Table 20: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 21: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031

    Table 22: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017‒2031

    Table 23: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017‒2031

    Table 24: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017‒2031

    Table 25: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017‒2031

    Table 26: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 27: Europe Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 28: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031

    Table 29: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 30: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031

    Table 31: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017‒2031

    Table 32: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017‒2031

    Table 33: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017‒2031

    Table 34: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017‒2031

    Table 35: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 36: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 37: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017‒2031

    Table 38: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 39: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017‒2031

    Table 40: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017‒2031

    Table 41: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017‒2031

    Table 42: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic Source, 2017‒2031

    List of Figures

    Figure 01: Global Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031

    Figure 02: Global Vascular Grafts Market Value Share, by Product, 2021

    Figure 03: Global Vascular Grafts Market Value Share, by Size of Vascular Graft, 2021

    Figure 04: Global Vascular Grafts Market Value Share, by Source, 2021

    Figure 04: Global Vascular Grafts Market Value Share, by Application, 2021

    Figure 04: Global Vascular Grafts Market Value Share, by End-user, 2021

    Figure 05: Global Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031

    Figure 06: Global Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031

    Figure 09: Global Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031

    Figure 10: Global Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031

    Figure 11: Global Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031

    Figure 12: Global Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031

    Figure 13: Global Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031

    Figure 14: Global Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 15: Global Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 16: Global Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 17: Global Vascular Grafts Market Value Share Analysis, by Region, 2021 and 2031

    Figure 18: Global Vascular Grafts Market Attractiveness Analysis, by Region, 2022–2031

    Figure 19: North America Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031

    Figure 20: North America Vascular Grafts Market Value Share Analysis, by Country, 2021 and 2031

    Figure 21: North America Vascular Grafts Market Attractiveness Analysis, by Country, 2022–2031 

    Figure 22: North America Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031

    Figure 23: North America Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031

    Figure 24: North America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031

    Figure 25: North America Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031

    Figure 26: North America Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031

    Figure 27: North America Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031

    Figure 28: North America Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031

    Figure 29: North America Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 30: North America Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 31: North America Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 32: Europe Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031

    Figure 33: Europe Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 34: Europe Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 35: Europe Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031

    Figure 36: Europe Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031

    Figure 37: Europe Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031

    Figure 38: Europe Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031

    Figure 39: Europe Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031

    Figure 40: Europe Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031

    Figure 41: Europe Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031

    Figure 42: Europe Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 43: Europe Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 44: Europe Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 45: Asia Pacific Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031

    Figure 46: Asia Pacific Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 47: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 48: Asia Pacific Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031

    Figure 49: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031

    Figure 50: Asia Pacific Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031

    Figure 51: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031

    Figure 52: Asia Pacific Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031

    Figure 53: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031

    Figure 54: Asia Pacific Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031

    Figure 55: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 56: Asia Pacific Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 57: Asia Pacific Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 58: Latin America Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031

    Figure 59: Latin America Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 60: Latin America Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2021-2031

    Figure 61: Latin America Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031

    Figure 62: Latin America Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031

    Figure 63: Latin America Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031

    Figure 64: Latin America Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031

    Figure 65: Latin America Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031

    Figure 66: Latin America Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031

    Figure 67: Latin America Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031

    Figure 68: Latin America Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 69: Latin America Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 70: Latin America Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 71: Middle East & Africa Vascular Grafts Market Value (US$ Bn) Forecast, 2017–2031

    Figure 72: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 73: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Country/Sub-region, 2021-2031

    Figure 74: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Product, 2021 and 2031

    Figure 75: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Product, 2022–2031

    Figure 76: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Size of Vascular Graft, 2021 and 2031

    Figure 77: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Size of Vascular Graft, 2022–2031

    Figure 78: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Source, 2021 and 2031

    Figure 79: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Source, 2022–2031

    Figure 80: Middle East & Africa Vascular Grafts Market Value Share Analysis, by Application, 2021 and 2031

    Figure 81: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by Application, 2022–2031

    Figure 82: Middle East & Africa Vascular Grafts Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 83: Middle East & Africa Vascular Grafts Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 84: Company Share Analysis, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved